A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity

Volume: 60, Issue: 23, Pages: 9575 - 9584
Published: Nov 17, 2017
Abstract
The 5-HT2CR agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT2CR allosteric modulators as safer antiobesity drugs, a chemical library from Vivia Biotech was screened using ExviTech platform. Structural modifications of identified hit VA240 in synthesized analogues 6–41 afforded compound 11...
Paper Details
Title
A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity
Published Date
Nov 17, 2017
Volume
60
Issue
23
Pages
9575 - 9584
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.